FADS2 and early-onset autosomal dominant Alzheimer disease: The results showed that potential intermediates between omega-3 fatty acids or FADS1/FADS2 genes and cognitive function were mostly associated with metabolic or neurological diseases, such as non-insulin dependent diabetes, metabolic syndrome, obesity and Alzheimer’s disease (Supplementary Table 11).